References: |
1. Butti, E., M. Bacigaluppi, S. Rossi, M. Cambiaghi, M. Bari, A. Cebrian Silla, E. Brambilla, A. Musella, R. De Ceglia, L. Teneud, V. De Chiara, P. D'Adamo, J.M. Garcia- Verdugo, G. Comi, L. Muzio, A. Quattrini, L. Leocani, M. Maccarrone, D. Centonze, and G. Martino, Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity. Brain, 2012. 135(Pt 11): p. 3320-35.
3. Hochgrafe, K., A. Sydow and E.M. Mandelkow, Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology. FEBS J, 2013. 280(18): p. 4371-81.
4. Mocanu, M.M., A. Nissen, K. Eckermann, I. Khlistunova, J. Biernat, D. Drexler, O. Petrova, K. Schonig, H. Bujard, E. Mandelkow, L. Zhou, G. Rune, and E.M. Mandelkow, The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J Neurosci, 2008. 28(3): p. 737-48.
5. Sydow, A., A. Van der Jeugd, F. Zheng, T. Ahmed, D. Balschun, O. Petrova, D. Drexler, L. Zhou, G. Rune, E. Mandelkow, R. D'Hooge, C. Alzheimer, and E.M. Mandelkow, Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J Neurosci, 2011. 31(7): p. 2511-25. |